A phase II, double-blind, randomised, placebo-controlled, multi-centre trial to assess the efficacy and safety of the 100 mg clindamycin hydrochloride vaginal insert in women diagnosed with bacterial vaginosis.
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2011
At a glance
- Drugs Clindamycin (Primary)
- Indications Bacterial infections; Bacterial vaginosis
- Focus Therapeutic Use
- Sponsors Controlled Therapeutics (Scotland)
- 20 Apr 2007 New trial record.